FR2460135A1 - Composition a usage externe a base de colostrum - Google Patents
Composition a usage externe a base de colostrum Download PDFInfo
- Publication number
- FR2460135A1 FR2460135A1 FR7917118A FR7917118A FR2460135A1 FR 2460135 A1 FR2460135 A1 FR 2460135A1 FR 7917118 A FR7917118 A FR 7917118A FR 7917118 A FR7917118 A FR 7917118A FR 2460135 A1 FR2460135 A1 FR 2460135A1
- Authority
- FR
- France
- Prior art keywords
- colostrum
- composition according
- composition
- external use
- tears
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000021277 colostrum Nutrition 0.000 title claims abstract description 26
- 210000003022 colostrum Anatomy 0.000 title claims abstract description 26
- 239000000203 mixture Substances 0.000 title claims abstract description 24
- 239000003889 eye drop Substances 0.000 claims abstract description 5
- 229940012356 eye drops Drugs 0.000 claims abstract description 5
- 239000002674 ointment Substances 0.000 claims abstract description 5
- 108010063045 Lactoferrin Proteins 0.000 claims description 6
- 102000012174 Lactotransferrin Human genes 0.000 claims description 6
- 239000011734 sodium Substances 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims description 2
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims description 2
- 239000002504 physiological saline solution Substances 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 3
- 230000001228 trophic effect Effects 0.000 abstract description 3
- 230000002421 anti-septic effect Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000006071 cream Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- -1 Urea Uric acid Sugars Chemical class 0.000 description 2
- 102000015395 alpha 1-Antitrypsin Human genes 0.000 description 2
- 108010050122 alpha 1-Antitrypsin Proteins 0.000 description 2
- 229940024142 alpha 1-antitrypsin Drugs 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229940055726 pantothenic acid Drugs 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 102100033312 Alpha-2-macroglobulin Human genes 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 108091006975 Iron transporters Proteins 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 102000012404 Orosomucoid Human genes 0.000 description 1
- 108010061952 Orosomucoid Proteins 0.000 description 1
- 108010015078 Pregnancy-Associated alpha 2-Macroglobulins Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 201000005485 Toxoplasmosis Diseases 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 208000030452 Transient pseudohypoaldosteronism Diseases 0.000 description 1
- IRWPIUQRYTZZSJ-UHFFFAOYSA-N [Cu].[Fe].[Mg].[Cl].[P].[Ca].[K].[Na] Chemical compound [Cu].[Fe].[Mg].[Cl].[P].[Ca].[K].[Na] IRWPIUQRYTZZSJ-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001420 bacteriolytic effect Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000000763 evoking effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/986—Milk; Derivatives thereof, e.g. butter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7917118A FR2460135A1 (fr) | 1979-07-02 | 1979-07-02 | Composition a usage externe a base de colostrum |
| MA19075A MA18877A1 (fr) | 1979-07-02 | 1980-06-19 | Procede de preparation de compositions a usage externe a base de colostrum |
| BE0/201117A BE883935A (fr) | 1979-07-02 | 1980-06-20 | Compositions a usage externe a base de colostrum |
| GB8020439A GB2052979B (en) | 1979-07-02 | 1980-06-23 | Ophthalmological use for colostrum |
| US06/163,189 US4342747A (en) | 1979-07-02 | 1980-06-26 | Colostrum-based composition for external use |
| DE19803024623 DE3024623A1 (de) | 1979-07-02 | 1980-06-30 | Mittel fuer aeusserliche anwendung auf der grundlage von kolostrum |
| JP8988780A JPS5653612A (en) | 1979-07-02 | 1980-07-01 | Novel composition based on first milk for external use |
| NL8003802A NL8003802A (nl) | 1979-07-02 | 1980-07-01 | Mengsel op basis van colostrum voor uitwendig gebruik. |
| CH505380A CH644269A5 (fr) | 1979-07-02 | 1980-07-01 | Composition a usage externe a base de colostrum. |
| IT68031/80A IT1130487B (it) | 1979-07-02 | 1980-07-01 | Composizione per l uso esterno a base di colostro |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR7917118A FR2460135A1 (fr) | 1979-07-02 | 1979-07-02 | Composition a usage externe a base de colostrum |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2460135A1 true FR2460135A1 (fr) | 1981-01-23 |
| FR2460135B1 FR2460135B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1982-11-19 |
Family
ID=9227385
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7917118A Granted FR2460135A1 (fr) | 1979-07-02 | 1979-07-02 | Composition a usage externe a base de colostrum |
Country Status (10)
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0334776A2 (fr) | 1988-03-25 | 1989-09-27 | Gattefosse S.A. | Composition cosmétique ou pharmaceutique à usage cutané, et procédé pour la préparation d'une telle composition |
| WO1995000155A1 (en) * | 1993-06-23 | 1995-01-05 | Viable Bioproducts Ltd. | Method for the improvement of wound healing and compositions therefor |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0188501A1 (en) * | 1984-07-13 | 1986-07-30 | Economix Közgazdasz Egyetemi Kisszövetkezet | Process for the preparation of a pharmaceutical composition influencing the tissue metabolism and having a regenerating action |
| FR2627386A1 (fr) * | 1988-02-22 | 1989-08-25 | Serge Liotet | Composition a usage externe destinee a l'administration oculaire |
| DE3924420A1 (de) * | 1989-07-24 | 1991-01-31 | Biotest Pharma Gmbh | Verfahren zur herstellung eines immunglobulin-praeparates aus kolostrum |
| DE4026365A1 (de) | 1990-08-21 | 1992-02-27 | Biotest Pharma Gmbh | Sterilfiltrierte kolostralmilch |
| EP0579830B1 (en) * | 1990-11-13 | 1997-02-05 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for corneal lesion |
| FR2676331B1 (fr) * | 1991-05-17 | 1993-09-03 | Opsia Pharma | Milieu de conservation d'organes, de tissus ou de cellules. |
| AU5833994A (en) * | 1993-01-26 | 1994-08-15 | Horse Vitality Ltd. | Pharmaceutical and dermocosmetic compositions containing equine colostrum |
| DE69528820T2 (de) * | 1995-04-28 | 2003-11-06 | Sara Lee/De N.V., Utrecht | Verwendung von Zahnpflegemitteln enthaltend bovines Kolostrum |
| JP3118584B2 (ja) * | 1995-05-08 | 2000-12-18 | 参天製薬株式会社 | 術後乱視予防剤 |
| DE19537297A1 (de) * | 1995-07-07 | 1997-01-09 | Paerson & Co Gmbh & Co | Kosmetische Präparate mit Wachstumsfaktoren hergestellt aus Milch und Kolostrum von Kühen und Stuten |
| AUPN642795A0 (en) | 1995-11-08 | 1995-11-30 | Northfield Laboratories Pty Ltd | Dairy compositions and methods of preparing same |
| US20030203839A1 (en) * | 1999-10-29 | 2003-10-30 | Kruzel Marian L. | Immune enhancing composition containing lactoferrin |
| US20060013889A1 (en) * | 2004-07-16 | 2006-01-19 | Playford Raymond J | Colostrum-based treatment for irritable bowel syndrome |
| US7426440B2 (en) * | 2004-09-24 | 2008-09-16 | Nutritional Bioscience Ltd. | Repair and protection factor scoring method for bioactive agents |
| US20060068022A1 (en) * | 2004-09-29 | 2006-03-30 | Playford Raymond J | Bioactive agent compositions for repair of cell injuries |
| WO2008103023A1 (en) * | 2007-02-20 | 2008-08-28 | N.V. Nutricia | Selected colostrum for treatment of intestinal barrier function disorders |
| JP6139562B2 (ja) * | 2011-12-30 | 2017-05-31 | イノメッド ソシエテ アノニム | 成長因子、サイトカイン、抗菌／抗ウイルス因子、幹細胞刺激因子、補体タンパク質ｃ３ａ／ｃ４ａ、免疫グロブリンおよび走化性因子の組合せ |
| ITMI20112440A1 (it) * | 2011-12-30 | 2013-07-01 | Bionest Ltd | Formulazioni contenenti citochine, fattori di crescita, chemiotattici, antibatterici ed eventualmente immunoglobuline e complemento, per la terapia topica delle lesioni corneali |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB467825A (en) * | 1935-12-23 | 1937-06-23 | Gyula Groh | Process for the production of substances for promoting the growth of backward infants |
| GB734117A (en) * | 1952-04-28 | 1955-07-27 | Evagoras Joannou Georgiou | Preparation of a substance for the treatment of malignant tumours |
| FR2360313A1 (fr) * | 1976-08-03 | 1978-03-03 | Fabre Sa Pierre | Compositions pharmaceutiques utiles notamment pour le traitement de la seborrhee |
| CH627079A5 (en) * | 1977-04-15 | 1981-12-31 | Nestle Sa | Process for preparing a protein concentrate containing immunological factors of milk origin |
-
1979
- 1979-07-02 FR FR7917118A patent/FR2460135A1/fr active Granted
-
1980
- 1980-06-19 MA MA19075A patent/MA18877A1/fr unknown
- 1980-06-20 BE BE0/201117A patent/BE883935A/fr not_active IP Right Cessation
- 1980-06-23 GB GB8020439A patent/GB2052979B/en not_active Expired
- 1980-06-26 US US06/163,189 patent/US4342747A/en not_active Expired - Lifetime
- 1980-06-30 DE DE19803024623 patent/DE3024623A1/de active Granted
- 1980-07-01 IT IT68031/80A patent/IT1130487B/it active
- 1980-07-01 CH CH505380A patent/CH644269A5/fr not_active IP Right Cessation
- 1980-07-01 NL NL8003802A patent/NL8003802A/nl not_active Application Discontinuation
- 1980-07-01 JP JP8988780A patent/JPS5653612A/ja active Granted
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0334776A2 (fr) | 1988-03-25 | 1989-09-27 | Gattefosse S.A. | Composition cosmétique ou pharmaceutique à usage cutané, et procédé pour la préparation d'une telle composition |
| FR2628973A1 (fr) * | 1988-03-25 | 1989-09-29 | Gattefosse Ets Sa | Composition cosmetique ou pharmaceutique a usage cutane, et procede pour la preparation d'une telle composition |
| EP0334776A3 (en) * | 1988-03-25 | 1989-10-11 | Gattefosse S.A. | Cosmetical or pharmaceutical composition for cutaneous application, and process for the manufacture of such a composition |
| WO1995000155A1 (en) * | 1993-06-23 | 1995-01-05 | Viable Bioproducts Ltd. | Method for the improvement of wound healing and compositions therefor |
Also Published As
| Publication number | Publication date |
|---|---|
| BE883935A (fr) | 1980-10-16 |
| JPH021127B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1990-01-10 |
| FR2460135B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1982-11-19 |
| GB2052979A (en) | 1981-02-04 |
| IT8068031A0 (it) | 1980-07-01 |
| US4342747A (en) | 1982-08-03 |
| DE3024623C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1989-10-26 |
| GB2052979B (en) | 1984-02-29 |
| NL8003802A (nl) | 1981-01-06 |
| DE3024623A1 (de) | 1981-01-22 |
| MA18877A1 (fr) | 1980-12-31 |
| IT1130487B (it) | 1986-06-11 |
| JPS5653612A (en) | 1981-05-13 |
| CH644269A5 (fr) | 1984-07-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2460135A1 (fr) | Composition a usage externe a base de colostrum | |
| KR100297959B1 (ko) | 유장단백질로hiv-혈청양성개체의치료방법 | |
| CA2330500A1 (fr) | Compositions pharmaceutiques gelifiables | |
| JP7397830B2 (ja) | 上皮組織におけるバリア欠陥を伴う疾患の予防または治療において使用するための適合溶質または溶質混合物 | |
| EP2068637A1 (fr) | Ingredient laitier enrichi en lipides polaires et applications de celui-ci | |
| JP4532900B2 (ja) | 細菌またはウイルス感染症の予防または治療における乳清アポタンパク質の使用 | |
| FR2698269A1 (fr) | Nouveaux médicaments à base d'acides gras insaturés, utilisables notamment comme antiagrégants plaquettaires et/ou comme transporteurs privilégiés vers le cerveau. | |
| CN112839670A (zh) | 可摄取的制剂 | |
| ATE261669T1 (de) | Fraktion basischer proteine aus milch als wirkstoff zur reduktion von bluthochdruck | |
| WO2014143275A1 (en) | Omega-3 pentaenoic acid compositions and methods of use | |
| US9283269B2 (en) | Method for reducing the allergenicity of animal dander | |
| CA2540539C (en) | A mixture for transdermal delivery of low and high molecular weight compounds comprising an ethoxylated oil | |
| EP1656131B1 (fr) | Utilisation de la betaine pour le traitement de la claudication intermittente | |
| EP0075523B1 (fr) | Nouveaux médicaments à base d'extraits d'algues, et formulations correspondantes | |
| JP4812968B2 (ja) | 注意欠陥多動性障害改善用組成物 | |
| WO2008151449A1 (en) | Method for the treatment of atopic eczema | |
| FR2627386A1 (fr) | Composition a usage externe destinee a l'administration oculaire | |
| KR20220045167A (ko) | 일반 의약품 및 의약품의 생체이용률을 증가시키는 방법 | |
| EP0083261B1 (fr) | Composition thérapeutique, à base d'inosine monophosphaté, pour le traitement des troubles d'accommodation de l'oeil | |
| EP1303296B1 (fr) | Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations | |
| EP1151754A1 (fr) | Utilisation d'une fraction du lait d'équidé pour l'inhibiton de la production de l'interleukine-1 | |
| CA2123585A1 (fr) | Composition lipidique polaire d'origine vegetale | |
| FR2561522A1 (fr) | Solution injectable, notamment pour le traitement de la cetose et son procede de preparation | |
| EP0615757A1 (fr) | Composition thérapeutique nouvelle ayant un effet immunostimulant | |
| WO2016051179A1 (en) | Composition comprising lactoferrine and methods of treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CL | Concession to grant licences | ||
| ST | Notification of lapse |